HR Execs on the Move

Terns Pharmaceuticals

www.ternspharma.com

 
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns` programs are based on clinically validated and complementary mechanisms of action to address the multiple hepatic disease processes of NASH in order to drive meaningful clinical benefits for patients. Terns` investors include OrbiMed, Vivo Capital, Lilly Asia Ventures, and Decheng Capital.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.ternspharma.com
  • 1065 East Hillsdale Boulevard Suite 100
    Foster City, CA USA 94404
  • Phone: 650.275.4395

Executives

Name Title Contact Details
Weidong Zhong
Founder and Chief Executive Officer Profile

Similar Companies

International Stem Cell Corporation

International Stem Cell Corporation is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

APT Pharmaceuticals

APT Pharmaceuticals, Inc is a Burlingame, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

GPX Update

Fluidx Medical Technologys novel GPX Embolic Device is a durable embolic that is easy to use, controllable, and effective for vessel occlusion.